Skip to content

Checked

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

NCT07444814 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Phase 1
Interventional
Planned enrollment
226
Participants, all sites
U.S. sites
12
In 10 states

Study details

Conditions
Endometrial Cancer, Ovarian Cancer, Ovarian Cancer Metastatic, Ovarian Cancer Metastatic Recurrent, Non-squamous EGFR Wt NSCLC, Platinum Resistant Ovarian Cancer, PROC
Sponsor
Whitehawk Therapeutics, Inc. (Industry)
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Start
12/19/2025
Primary completion (expected)
October 2028
Last updated by sponsor
08/05/2026

Full eligibility rules, contacts and site names: NCT07444814 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Arkansas: Little Rock
  • California: Los Angeles
  • Illinois: Peoria
  • Michigan: Grand Rapids
  • New Jersey: Hackensack
  • New York: Buffalo
  • Ohio: Cleveland
  • Texas: Austin, Houston, San Antonio
  • Virginia: Fairfax
  • Washington: Seattle

More studies on the same topic

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 08/05/2026